Know Cancer

or
forgot password
  • cancer clinical trials in new mexico

  • Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects
    GSK Investigational Site
    Albuquerque, New Mexico 87109
    Human Papillomavirus (HPV) Type 16/18 Infections, Cervical Neoplasia
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    University of New Mexico
    Albuquerque, New Mexico 87131
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Southwest Gynecologic Oncology Associates, Incorporated
    University of New Mexico Cancer Center - South
    Endometrial Cancer
    Study of Patients With Advanced Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Albuquerque, New Mexico 87106
    Advanced Non-Small Cell Lung Cancer
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Southwest Gynecologic Oncology Associates Inc
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Southwest Gynecologic Oncology Associates, Incorporated
    Ovarian Cancer, Sarcoma
    Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Southwest Gynecologic Oncology Associates, Incorporated

    Trial Locations
    Southwest Gynecologic Oncology Associates, Incorporated
    University of New Mexico Cancer Center - South
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Psychosocial Effects of Cancer and Its Treatment
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Southwest Gynecologic Oncology Associates Inc
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Use of Hydralzaine and Valproic Acid in Advanced Solid Tumor Malignancies
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Lung Cancer
    Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma
    University of New Mexico

    Trial Locations
    University of New Mexico
    Lovelace Women's Hospial
    Melanoma
    Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma
    The Cancer Center at Presbyterian
    Albuquerque, New Mexico 87110
    Melanoma
    Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Lovelace Medical Center - Downtown
    Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital
    Breast Cancer, Cardiac Toxicity
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Hematology Oncology Associates, PC
    Albuquerque, New Mexico 87106
    Colorectal Cancer, Precancerous Condition
    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Southwest Gynecologic Oncology Associates Inc
    Memorial Medical Center - Las Cruces
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
    Presbyterian Medical Group

    Trial Locations
    Presbyterian Medical Group
    University of New Mexico Cancer Care Alliance
    Renal Cell Carcinoma
    Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Lung Cancer
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Survey of Inhibitors in Plasma-Product Exposed Toddlers
    University of New Mexico, Dept. of Pediatrics
    Albuquerque, New Mexico 87131
    Hemophilia A
    Immunotherapy Study for Surgically Resected Pancreatic Cancer
    University of New Mexico
    Albuquerque, New Mexico 87131
    Pancreatic Cancer
    PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
    Presbyterian Medical Group

    Trial Locations
    Presbyterian Medical Group
    University of New Mexico Cancer Care Alliance
    Breast Cancer
    Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital
    Breast Cancer
    S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
    Lovelace Medical Center - Downtown
    Albuquerque, New Mexico 87102
    brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer
    Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    The Cancer Center at Presbyterian
    Memorial Medical Center- Cancer Center
    Metastatic Renal Cell Carcinoma
    Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Southwest Gynecologic Oncology Associates, Incorporated
    University of New Mexico Cancer Center - South
    Cervical Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Hematology Oncology Associates, PC

    Trial Locations
    Hematology Oncology Associates, PC
    Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital
    Kidney Cancer
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    University of New Mexico Cancer Center - South
    Las Cruces, New Mexico 88011
    Breast Cancer